Study of the Effects of Lovaza (Omega 3 Fatty Acids) On Lipoprotein Particles and Their Transcriptional Effects
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Omega-3-fatty-acid (Primary)
- Indications Hypertriglyceridaemia
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jul 2012 Planned end date changed from 1 Mar 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.